AXSOME THERAPEUTICS INC NASDAQ:​AXSM

 
     
 
     
Prev
 
Open
 
Volume
 
1 Day Range
  -  
EPS
 
Mkt Cap
 
PE
 
Div Yield
 
Popular Today
Popular Today
Popular All Time
Newest
Charts and Videos
Charts and Videos
Charts
Videos

Technicals

Profile

Financials

Price History
Average Volume (10 day) ---
Beta - 1 Year ---
Price - 52 Week High ---
Price - 52 Week Low ---
Valuation
Enterprise Value/EBITDA, TTM ---
Enterprise Value, FQ ---
Market Cap - Basic ---
Number of Employees ---
Number of Shareholders ---
Price/Earnings, TTM ---
Price/Revenue, TTM ---
Price/Book Ratio, FY ---
Price/Sales Ratio, FY ---
Dividends
Dividends Paid, FY ---
Dividends per Share, FQ ---
Expected Annual Dividends ---
Dividends Yield ---
Margins
Net Margin, TTM ---
Gross Margin, TTM ---
Operating Margin, TTM ---
Pretax Margin, TTM ---
Balance Sheet
Current Ratio, FQ ---
Debt to Equity, FQ ---
Net Debt, FQ ---
Quick Ratio, FQ ---
Total Assets, FQ ---
Total Debt, FQ ---
Income Statement
Basic EPS, Net Income ---
Earnings per Share, Basic, TTM ---
EBITDA, TTM ---
Gross Profit, FY ---
Last Annual EPS ---
Last Annual Revenue, FY ---
Net Income, FY ---
Total Revenue, FY ---
Free Cash Flow, TTM ---
Operating Metrics
Return on Assets, TTM ---
Return on Equity, TTM ---
Return on Invested Capital, TTM ---
Revenue per Employee, TTM ---

News

nl8899 nl8899 AXSM, D, Long ,
25 0 0
AXSM, D Long
Axsome Therapeutics: AXSM

Proffesional activity. Looking for BUY

37 0 5
AXSM, D
AXSM: biotech stock: one to watch

Possible double bottom. Watch if holds here. See “the gold bags” post: https://www.tradingview.com/chart/AXSM/di8zNJvb-AXSM-could-be-the-next-4-6-bagger-biotechstock/ News today: https://finance.yahoo.com/news/axsome-therapeutics-announces-axs-02-120000137.html

thegoldenbags thegoldenbags AXSM, W, Long ,
160 2 2
AXSM, W Long
AXSM could be the next 4 - 6 bagger biotechstock

Cash: $41 Million (cash runway into the second quarter of 2019) Phase 3 CREATE-1 trial of AXS-02 in CRPS, interim efficacy analysis (late December 2017 to early January 2018) •Phase 3 COAST-1 trial of AXS-02 in knee OA associated with BMLs, interim analysis (late December 2017 to early January 2018) •Phase 3 STRIDE-1 trial of AXS-05 in TRD, top-line data (1H ...

Digital-Physics Digital-Physics AXSM, 120, Long ,
32 0 1
AXSM, 120 Long
Second Axsome AXSM buy opportunity

Current share price is testing the upward trending lower resistance line. As the lower resistance line crosses the $5 inflection line we could expect major movement ahead of the Q42017/Q12018 FDA catalysts.

55 0 2
AXSM, 60 Long
Axsome Buy Opportunity

Pushing down against the lower resistance line. Buy ahead of upcoming PDUFA catalyst

BVDP BVDP AXSM, D, Long ,
28 0 2
AXSM, D Long
AXSM - moving averages also lining up perfectly

Just watching this one unfold in a monster...

BVDP BVDP AXSM, D, Long ,
50 0 2
AXSM, D Long
AXSM - Bill Williams - Alligator waking up

Something's up. Not sure why, but technicals turning into a perfect storm upward ...

BVDP BVDP AXSM, D, Long ,
25 0 2
AXSM, D Long
AXSM : Golden Cross anytime soon now

... and plenty of catalysts ahead for long-time investors too :D

BVDP BVDP AXSM, D, Long ,
14 0 0
AXSM, D Long
AXSM still going strong

Might be big moves ahead ...

baumberg baumberg AXSM, W, Long ,
36 0 6
AXSM, W Long
Three of three

1. I believe I see some bullish signs in the sector in general (IBB) and I want to get some exposure. 2. My friend who's doing fundamental analysis of biotech stocks, told me to look at this stock. He says they have enough money to sustain themselves for a while and some potential price catalysts in the not so distant future. 3. The chart looks to me like it ...

BVDP BVDP AXSM, D, Long ,
32 0 6
AXSM, D Long
AXSM next to high expectations, building itself momentum

AXSM is as of lately recruiting heavy hitter Executives that are extremely experienced and successful in the field of commercialisation and take-over, which seems to be the next step here. Apart from great Intitutional Holdings, Insider Holdings and cash at hand (good to go until Q1 2019), quite some catalysts are around the corner. Oh, and chart lookes great too ;)

AntonioNaVi AntonioNaVi AXSM, D, Long ,
29 0 3
AXSM, D Long
gap breakout with nice R/B

Long >3.86 Stop - 3.72 Target - 4.29

sreesweth sreesweth AXSM, D, Long ,
14 0 1
AXSM, D Long
AXSOME Therapeutics is a Stock to watch

AXSM is a Pharma company and is discounted over 40% from its high. The stock looks to break out of its consolidation phase. MACD looks positive, Boiling Band(BB) looks impressive, and what stands out is the way stock price has crossed 50 day MA and 100 Day MA. The next few days will give a clear indication of its positive moment. However, the stock looks like its ...

EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out
Browse
Video